Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 226

1.

Medical Evaluation Board for Mental Health Condition: U.S. Army Officer Medical Evaluation Board Data by Branch and Component.

Thomas WA Jr, Doane EL, Gallavan RH, Tavares S, Jones MC.

Mil Med. 2017 Sep;182(9):e1908-e1916. doi: 10.7205/MILMED-D-17-00041.

PMID:
28885954
2.

α-Catenin and vinculin cooperate to promote high E-cadherin-based adhesion strength.

Thomas WA, Boscher C, Chu YS, Cuvelier D, Martinez-Rico C, Seddiki R, Heysch J, Ladoux B, Thiery JP, Mege RM, Dufour S.

J Biol Chem. 2013 Feb 15;288(7):4957-69. doi: 10.1074/jbc.M112.403774. Epub 2012 Dec 24.

3.

The relationship between local public health agency characteristics and performance of partnership-related essential public health services.

Downey LH, Thomas WA Jr, Gaddam R, Scutchfield FD.

Health Promot Pract. 2013 Mar;14(2):284-92. doi: 10.1177/1524839912455332. Epub 2012 Sep 14.

PMID:
22982708
4.

Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.

Zuo J, Thomas WA, Haigh TA, Fitzsimmons L, Long HM, Hislop AD, Taylor GS, Rowe M.

PLoS Pathog. 2011 Dec;7(12):e1002455. doi: 10.1371/journal.ppat.1002455. Epub 2011 Dec 22.

5.

The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways.

Zuo J, Quinn LL, Tamblyn J, Thomas WA, Feederle R, Delecluse HJ, Hislop AD, Rowe M.

J Virol. 2011 Feb;85(4):1604-14. doi: 10.1128/JVI.01608-10. Epub 2010 Dec 1.

6.

Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.

Amoroso R, Fitzsimmons L, Thomas WA, Kelly GL, Rowe M, Bell AI.

J Virol. 2011 Jan;85(2):996-1010. doi: 10.1128/JVI.01528-10. Epub 2010 Nov 10.

7.

Evaluating a deer-targeted acaricide applicator for area-wide suppression of blacklegged ticks, Ixodes scapularis (Acari: Ixodidae), in Rhode Island.

Miller NJ, Thomas WA, Mather TN.

Vector Borne Zoonotic Dis. 2009 Aug;9(4):401-6. doi: 10.1089/vbz.2008.0164.

PMID:
19650734
8.

You're the flight surgeon. Hepatitis C.

Thomas WA Jr.

Aviat Space Environ Med. 2009 Jun;80(6):579-80. No abstract available.

PMID:
19569276
9.

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.

Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, Bell AI, Bornkamm GW, Mautner J, Rickinson AB, Rowe M.

PLoS Pathog. 2009 Mar;5(3):e1000341. doi: 10.1371/journal.ppat.1000341. Epub 2009 Mar 13.

10.

Cyclical expression of EBV latent membrane protein 1 in EBV-transformed B cells underpins heterogeneity of epitope presentation and CD8+ T cell recognition.

Brooks JM, Lee SP, Leese AM, Thomas WA, Rowe M, Rickinson AB.

J Immunol. 2009 Feb 15;182(4):1919-28. doi: 10.4049/jimmunol.0713607.

11.

The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation.

Zuo J, Currin A, Griffin BD, Shannon-Lowe C, Thomas WA, Ressing ME, Wiertz EJ, Rowe M.

PLoS Pathog. 2009 Jan;5(1):e1000255. doi: 10.1371/journal.ppat.1000255. Epub 2009 Jan 2.

12.

Prototypical type I E-cadherin and type II cadherin-7 mediate very distinct adhesiveness through their extracellular domains.

Chu YS, Eder O, Thomas WA, Simcha I, Pincet F, Ben-Ze'ev A, Perez E, Thiery JP, Dufour S.

J Biol Chem. 2006 Feb 3;281(5):2901-10. Epub 2005 Oct 26.

13.

Force measurements in E-cadherin-mediated cell doublets reveal rapid adhesion strengthened by actin cytoskeleton remodeling through Rac and Cdc42.

Chu YS, Thomas WA, Eder O, Pincet F, Perez E, Thiery JP, Dufour S.

J Cell Biol. 2004 Dec 20;167(6):1183-94. Epub 2004 Dec 13.

14.

CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.

Lee SP, Brooks JM, Al-Jarrah H, Thomas WA, Haigh TA, Taylor GS, Humme S, Schepers A, Hammerschmidt W, Yates JL, Rickinson AB, Blake NW.

J Exp Med. 2004 May 17;199(10):1409-20.

15.
16.

CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells.

Lee SP, Chan AT, Cheung ST, Thomas WA, CroomCarter D, Dawson CW, Tsai CH, Leung SF, Johnson PJ, Huang DP.

J Immunol. 2000 Jul 1;165(1):573-82.

17.
18.

Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.

Lee SP, Tierney RJ, Thomas WA, Brooks JM, Rickinson AB.

J Immunol. 1997 Apr 1;158(7):3325-34.

PMID:
9120290
19.
20.

Supplemental Content

Loading ...
Support Center